Avricore Current Deferred Revenue from 2010 to 2026
| AVCR Stock | CAD 0.07 0.01 7.14% |
Current Deferred Revenue | First Reported 2010-12-31 | Previous Quarter 289.8 K | Current Value 304.3 K | Quarterly Volatility 146.1 K |
Check Avricore Health financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Avricore Health's main balance sheet or income statement drivers, such as Selling General Administrative of 1.2 M, Other Operating Expenses of 1.7 M or Operating Income of 131.7 K, as well as many indicators such as Price To Sales Ratio of 0.99, Dividend Yield of 0.0 or PTB Ratio of 3.06. Avricore financial statements analysis is a perfect complement when working with Avricore Health Valuation or Volatility modules.
Avricore | Current Deferred Revenue |
The evolution of Current Deferred Revenue for Avricore Health provides essential context for understanding the company's financial health trajectory. By analyzing this metric's behavior over time, investors can assess whether recent trends align with long-term patterns, and how Avricore Health compares to historical norms and industry peers.
Latest Avricore Health's Current Deferred Revenue Growth Pattern
Below is the plot of the Current Deferred Revenue of Avricore Health over the last few years. It is revenue that has been collected but not yet earned, typically from prepaid service contracts or subscriptions. This amount is considered a liability until the service is provided or the subscription period ends. Avricore Health's Current Deferred Revenue historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Avricore Health's overall financial position and show how it may be relating to other accounts over time.
| Current Deferred Revenue | 10 Years Trend |
|
Current Deferred Revenue |
| Timeline |
Avricore Current Deferred Revenue Regression Statistics
| Arithmetic Mean | 51,182 | |
| Geometric Mean | 70,072 | |
| Coefficient Of Variation | 285.55 | |
| Mean Deviation | 128,727 | |
| Median | (40,000) | |
| Standard Deviation | 146,150 | |
| Sample Variance | 21.4B | |
| Range | 344.3K | |
| R-Value | 0.80 | |
| Mean Square Error | 8.2B | |
| R-Squared | 0.64 | |
| Significance | 0.0001 | |
| Slope | 23,144 | |
| Total Sum of Squares | 341.8B |
Avricore Current Deferred Revenue History
About Avricore Health Financial Statements
Avricore Health investors use historical fundamental indicators, such as Avricore Health's Current Deferred Revenue, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Avricore Health. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Current Deferred Revenue | 289.8 K | 304.3 K |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Avricore Stock Analysis
When running Avricore Health's price analysis, check to measure Avricore Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Avricore Health is operating at the current time. Most of Avricore Health's value examination focuses on studying past and present price action to predict the probability of Avricore Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Avricore Health's price. Additionally, you may evaluate how the addition of Avricore Health to your portfolios can decrease your overall portfolio volatility.